from the wiki
Tsutomu Yamaguchi (March 16, 1916 – January 4, 2010) was a survivor of both the Hiroshima and Nagasaki atomic bombings during World War II. He is the only person to have been officially recognized by the government of Japan as surviving both explosions.
Yamaguchi, a resident of Nagasaki, was in Hiroshima on business for his employer Mitsubishi Heavy Industries when the city was bombed at 8:15 am, on August 6, 1945. He returned to Nagasaki the following day, and despite his wounds, he returned to work on August 9, the day of the second atomic bombing. That morning he was telling his supervisor how one bomb had destroyed the city, to which his supervisor told him that he was crazy, and at that moment the Nagasaki bomb detonated. His workplace again put him 3 km from ground zero, but this time he was unhurt by the explosion. However, he was unable to replace his now ruined bandages, and he suffered from a high fever for over a week.
When the war ended, Yamaguchi worked as a translator for the occupying American Marines and then became a schoolmaster. When the Japanese government officially recognized atomic bombing survivors as hibakusha in 1957, Yamaguchi’s identification stated only that he had been present at Nagasaki. He was content with this, satisfied that he was relatively healthy, and put the experiences behind him. As he grew older, his opinions about the use of atomic weapons began to change. In his eighties, he wrote a book about his experiences as well as a book of poetry.
It was not until March 24, 2009, that the government of Japan officially recognized his presence in Hiroshima three days earlier. “It was my destiny that I experienced this twice and I am still alive to convey what happened,” he said.
Yamaguchi lost hearing in his left ear as a result of the Hiroshima explosion. He also went bald temporarily and his daughter recalls that he was constantly swathed in bandages until she reached the age of 12. Late in his life, he began to suffer from radiation-related ailments, including cataracts and acute leukemia.